on Relief Therapeutics Holding SA (ETR:RLF)
Relief Therapeutics Advances 2025 Half-Year Report Publication
Relief Therapeutics Holding SA has announced that it will release its 2025 half-year report earlier than planned. Initially set for August 27, the report will now be available on August 14. This decision follows the anticipated early completion of the report, which includes a shareholder update and interim financial statements.
Relief Therapeutics is a biopharmaceutical company focusing on innovative treatments for rare and unmet medical conditions. The company is headquartered in Geneva and is listed on the SIX Swiss Exchange and OTCQB in the U.S.
The report will be accessible on the company's website at the time of publication.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Relief Therapeutics Holding SA news